180 related articles for article (PubMed ID: 34270097)
1. Radiological assessment of persistent retroperitoneal and lateral pelvic lymph nodes after neoadjuvant therapy for rectal cancer: An analysis of the United States Rectal Cancer Consortium.
Turgeon MK; Gamboa AC; Keilson JM; Maniko J; Maguire L; Hrebinko K; Holder-Murray J; Wiseman JT; Abdel-Misih S; Hamdan S; Hawkins AT; Bauer P; Silviera M; Maithel SK; Balch GC
J Surg Oncol; 2021 Oct; 124(5):818-828. PubMed ID: 34270097
[TBL] [Abstract][Full Text] [Related]
2. Retroperitoneal and lateral pelvic lymphadenectomy mapped by lymphoscintigraphy and blue dye for rectal adenocarcinoma staging: preliminary results.
Quadros CA; Lopes A; Araújo I; Fahel F; Bacellar MS; Dias CS
Ann Surg Oncol; 2006 Dec; 13(12):1617-21. PubMed ID: 17009148
[TBL] [Abstract][Full Text] [Related]
3. Oncological Outcomes of Patients with Locally Advanced Rectal Cancer and Lateral Pelvic Lymph Node Involvement.
Sapci I; Delaney CP; Liska D; Amarnath S; Kalady MF; Steele SR; Gorgun E
J Gastrointest Surg; 2019 Jul; 23(7):1454-1460. PubMed ID: 31012043
[TBL] [Abstract][Full Text] [Related]
4. Retroperitoneal and lateral pelvic lymphadenectomy mapped by lymphoscintigraphy for rectal adenocarcinoma staging.
Quadros CA; Lopes A; Araújo I
Jpn J Clin Oncol; 2010 Aug; 40(8):746-53. PubMed ID: 20457722
[TBL] [Abstract][Full Text] [Related]
5. Metastases to retroperitoneal or lateral pelvic lymph nodes indicated unfavorable survival and high pelvic recurrence rates in a cohort of 102 patients with low rectal adenocarcinoma.
Quadros CA; Falcão MF; Carvalho ME; Ladeia PA; Lopes A
J Surg Oncol; 2012 Nov; 106(6):653-8. PubMed ID: 22535617
[TBL] [Abstract][Full Text] [Related]
6. Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?
Hughes R; Glynne-Jones R; Grainger J; Richman P; Makris A; Harrison M; Ashford R; Harrison RA; Livingstone JI; McDonald PJ; Meyrick Thomas J; Mitchell IC; Northover JM; Phillips R; Wallace M; Windsor A; Novell JR
Int J Colorectal Dis; 2006 Jan; 21(1):11-7. PubMed ID: 15864605
[TBL] [Abstract][Full Text] [Related]
7. The Addition of Preoperative Radiation Is Insufficient for Lateral Pelvic Control in a Subgroup of Patients With Low Locally Advanced Rectal Cancer: A Post Hoc Study of a Randomized Controlled Trial.
Xie Y; Lin J; Wang X; Wang P; Zhuang Z; Zou Q; Cai D; Huang Z; Bai L; Tang G; Huang M; Wang J; Yu H; Luo Y
Dis Colon Rectum; 2021 Nov; 64(11):1321-1330. PubMed ID: 33990500
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemoradiotherapy affects the indications for lateral pelvic node dissection in mid/low rectal cancer with clinically suspected lateral node involvement: a multicenter retrospective cohort study.
Oh HK; Kang SB; Lee SM; Lee SY; Ihn MH; Kim DW; Park JH; Kim YH; Lee KH; Kim JS; Kim JW; Kim JH; Chang TY; Park SC; Sohn DK; Oh JH; Park JW; Ryoo SB; Jeong SY; Park KJ
Ann Surg Oncol; 2014 Jul; 21(7):2280-7. PubMed ID: 24604580
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with lateral pelvic recurrence after curative resection following neoadjuvant chemoradiotherapy in rectal cancer patients.
Kim TG; Park W; Choi DH; Park HC; Kim SH; Cho YB; Yun SH; Kim HC; Lee WY; Lee J; Park JO; Park YS; Lim HY; Kang WK; Chun HK
Int J Colorectal Dis; 2014 Feb; 29(2):193-200. PubMed ID: 24322736
[TBL] [Abstract][Full Text] [Related]
10. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
11. Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study.
Räsänen M; Renkonen-Sinisalo L; Mustonen H; Lepistö A
World J Surg Oncol; 2019 Aug; 17(1):139. PubMed ID: 31395058
[TBL] [Abstract][Full Text] [Related]
12. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of neoadjuvant therapy followed by selective inguinal lymph node dissection and total mesorectal excision for metastasized low rectal cancer.
Hasegawa H; Matsuda T; Yamashita K; Sawada R; Harada H; Urakawa N; Goto H; Kanaji S; Oshikiri T; Kakeji Y
Langenbecks Arch Surg; 2022 Dec; 408(1):2. PubMed ID: 36577899
[TBL] [Abstract][Full Text] [Related]
14. Impact of Total Lymph Node Count on Staging and Survival After Neoadjuvant Chemoradiation Therapy for Rectal Cancer.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Kim J; Wong JY; Chen YJ
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S580-7. PubMed ID: 25956577
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Different Nodal Staging in Patients With Locally Advanced Mid-low Rectal Cancer After Long-term Neoadjuvant Chemoradiation Therapy.
Petrucciani N; Carra MC; Martínez-Pérez A; Vitali GC; Landi F; Genova P; Memeo R; Brunetti F; Espin E; Ris F; De'angelis N;
Anticancer Res; 2019 Apr; 39(4):2113-2120. PubMed ID: 30952757
[TBL] [Abstract][Full Text] [Related]
16. NEOADJUVANT THERAPY AND SURGERY FOR RECTAL CANCER. Comparative study between partial and complete pathological response.
Andrade VA; Coy CS; Leal RF; Fagundes JJ; Martinez CA; Ayrizono Mde L
Arq Gastroenterol; 2016; 53(3):163-8. PubMed ID: 27438421
[TBL] [Abstract][Full Text] [Related]
17. Reduction in the size of enlarged pelvic lymph nodes after chemoradiation therapy is associated with fewer lymph node metastases in locally advanced rectal carcinoma.
Morimoto M; Miyakura Y; Lefor AT; Takahashi K; Horie H; Koinuma K; Tanaka H; Ito H; Shimizu T; Kono Y; Sata N; Fukushima N; Sakatani T; Yasuda Y
Surg Today; 2015 Jul; 45(7):834-40. PubMed ID: 25119163
[TBL] [Abstract][Full Text] [Related]
18. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
[TBL] [Abstract][Full Text] [Related]
19. The total number of lymph nodes harvested from pathological T3N0 rectal cancer patients: Prognostic significance and potential indication for postoperative radiotherapy.
Xiao WW; Zhang LN; You KY; Huang R; Yu X; Chang H; Ding PR; Gao YH
J Cancer Res Ther; 2018 Jun; 14(Supplement):S288-S294. PubMed ID: 29970678
[TBL] [Abstract][Full Text] [Related]
20. Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns.
Yamamoto T; Kawada K; Hida K; Ganeko R; Inamoto S; Yoshitomi M; Watanabe T; Sakai Y
Int J Clin Oncol; 2019 Jun; 24(6):677-685. PubMed ID: 30721379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
